Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, randomised, double-blind, placebo- and active-controlled trial

被引：6
|
作者：
Lieberman, J. A. [1 ]
Cutler, A. J. [2 ]
Wan, S. [3 ]
Migliore, R. [3 ]
Ruth, A. [4 ]
Laszlovszky, I. [5 ]
Nemeth, G. [5 ]
Durgam, S. [3 ]
机构：
[1] Columbia Univ Med Ctr, New York, NY 10032 USA
[2] Florida Clin Res Ctr LLC, Bradenton, FL USA
[3] Forest Res Inst, Jersey City, NJ 07311 USA
[4] Prescott Med Commun Grp, Chicago, IL USA
[5] Gedeon Richter Plc, Budapest, Hungary
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70756-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.033
引用
收藏
页码：S477 / S478
页数：2
相关论文
共 50 条
  • [1] Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial
    Durgam, Suresh
    Cutler, Andrew J.
    Lu, Kaifeng
    Migliore, Raffaele
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Meltzer, Herbert Y.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (12) : E1574 - +
  • [2] Cariprazine in negative symptoms of schizophrenia: post hoc analyses of a fixed-dose, placebo- and active-controlled trial
    Debelle, M.
    Faradzs-zade, S.
    Szatmari, B.
    Nagy, K.
    Nemeth, G.
    Durgam, S.
    Laszlovszky, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S534 - S534
  • [3] Cariprazine in Negative Symptoms of Schizophrenia: Post-hoc Analyses of a Fixed-dose Phase Iii, Randomized, Double-blind, Placebo-and Active-controlled Trial
    Debelle, M.
    Faradzs-zade, S.
    Szatmari, B.
    Nagy, K.
    Nemeth, G.
    Durgam, S.
    Laszlovszky, I.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [4] TRAJECTORY OF CARIPRAZINE TREATMENT EFFECTS ACROSS SCHIZOPHRENIA SYMPTOMS: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL
    Cutler, Andrew J.
    Durgam, Suresh
    Lu, Kaifeng
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Meltzer, Herbert Y.
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S308 - S308
  • [5] Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control
    Landbloom, Ronald
    Mackle, Mary
    Wu, Xiao
    Kelly, Linda
    Snow-Adami, Linda
    McIntyre, Roger S.
    Mathews, Maju
    Hundt, Carla
    [J]. CNS SPECTRUMS, 2017, 22 (04) : 333 - 341
  • [6] Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials
    Durgam, S.
    Earley, W.
    Lu, K.
    Nemeth, G.
    Laszlovszky, I.
    Szatmari, B.
    Edwards, J.
    Nasrallah, H. A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S552 - S552
  • [7] Cariprazine for Negative Symptoms of Schizophrenia: Pooled Post Hoc Analysis of 2 Randomized, Double-Blind, Placebo- and Active-Controlled Trials
    Earley, Willie
    Durgam, Suresh
    Debelle, Marc
    Laszlovszky, Istvan
    Lu, Kaifeng
    Nasrallah, Henry
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S233 - S234
  • [8] Efficacy of Cariprazine Across Schizophrenia Symptoms: A Post Hoc Analysis of PANSS Data from a Phase III, Double-blind, Placebo- and Active-controlled Trial
    Zukin, Stephen R.
    Lieberman, Jeffrey A.
    Cutler, Andrew J.
    Lu, Kaifeng
    Migliore, Raffaele
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Durgam, Suresh
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S379 - S380
  • [9] Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial
    Berger, William E.
    Milgrom, Henry
    Skoner, David P.
    Tripp, Kenneth
    Parsey, Merdad V.
    Baumgartner, Rudolf A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (06) : 1217 - 1226
  • [10] Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia: Sub-analysis of a double-blind, placebo- and active-controlled study
    Beuzen, J. -N
    Hanssens, L.
    McQuade, R.
    Manos, G.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S283 - S283
12345